Cycclone Inc.
CYCL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.39M
Close$
$-0.00
104.4% downside
Current Fair Value
104.4% downsideOvervalued by 104.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.39 Million |
|---|---|
| Enterprise Value | $1.44 Million |
| Earnings per Share | $0 |
| Beta | 0.81 |
| Outstanding Shares | 40,976,000 |
Return
| Return on Equity | 3975.74% |
|---|---|
| Return on Assets | -100.12% |
| Return on Invested Capital | 4545.70% |
Valuation & Multiples
| P/E Ratio | -34 |
|---|---|
| PEG | 33.54 |
| Price to Sales | - |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -17.42 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | -24.17 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 10, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Cycclone Inc.
689 employees
CEO: Michael Nugent
Cycclone Inc., operating with its subsidiaries, specializes in the development, promotion, and distribution of bacteria-derived products. These offerings primarily function as beneficial additives for both agricultural crops and animal f...